Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a non » _ non (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a non » _ non (Expand Search)
-
1041
-
1042
-
1043
-
1044
-
1045
-
1046
-
1047
-
1048
-
1049
Viability of <i>MRE11</i>, <i>mre11A470T</i>, <i>rap1-5</i>, <i>and mre11A470T rap1-5</i>.
Published 2017“…<i>mre11A470T</i> and <i>mre11A470T rap1-5</i> cells had decreased viability only at 37°C. …”
-
1050
-
1051
-
1052
-
1053
-
1054
-
1055
-
1056
-
1057
EIF5A2 or MTA1 expression levels influenced the aggressiveness of GC cells in vitro.
Published 2015“…<p>(<b>A</b>) Proliferation of EIF5A2-targeted siRNA (T1-siRNA) and non-targeted control (NC) HGC27 cells were measured by CCK-8 assay every 24 h after siRNA transfection. …”
-
1058
Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF
Published 2018“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
-
1059
Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF
Published 2018“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
-
1060
Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX
Published 2018“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”